Hugh Wight

Chief Tech/Sci/R&D Officer at ALLENA PHARMACEUTICALS, INC.

Health Technology

Consumer Services

Active connections

Name	Gender	Age	Linked companies	Collaboration
Alexey L. Margolin	M	71	ALLENA PHARMACEUTICALS, INC. Alnara Pharmaceuticals, Inc. Alnara Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alnara Pharmaceuticals, Inc. develops and commercializes protein therapeutics for the treatment of metabolic diseases. It also develops liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT) for the treatment of exocrine pancreatic insufficiency (EPI). The company was founded by Christoph H. Westphal, Richard H. Aldrich and Alexy L. Margolin in 2008 and is headquartered in Boston, MA.	16 years
Mark J. Fitzpatrick	M	61	ALLENA PHARMACEUTICALS, INC.	3 years
Geoffrey A. Swire	M	-	ALLENA PHARMACEUTICALS, INC.	6 years
Ann Miller	M	66	ALLENA PHARMACEUTICALS, INC.	4 years
Matthew Foster	M	-	ALLENA PHARMACEUTICALS, INC.	2 years

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
Jane L. Caron	F	-	University of Maine	7 years
Andrew Frawley	M	61	University of Maine	4 years
Charles N. Kasmer	M	-	University of Maine	4 years
Dean H. Murray	M	-	University of Maine	5 years
Ray Carter	M	-	University of Maine	4 years
Joe A. Farrell	M	-	University of Maine	3 years
Jon W. Chadbourne	M	-	University of Maine	4 years
David Nonis	M	-	University of Maine	4 years
Michael W. Murphy	M	-	University of Maine	3 years
Wayne Steller	M	-	University of Maine	4 years
Michael Martin Young	M	-	University of Maine	4 years
Michael Bilodeau	M	62	University of Maine	4 years
James M. Rice	M	-	University of Maine	4 years
John Beaupre	M	-	University of Maine	4 years
Chris Stevens	M	65	Alnara Pharmaceuticals, Inc. Alnara Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alnara Pharmaceuticals, Inc. develops and commercializes protein therapeutics for the treatment of metabolic diseases. It also develops liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT) for the treatment of exocrine pancreatic insufficiency (EPI). The company was founded by Christoph H. Westphal, Richard H. Aldrich and Alexy L. Margolin in 2008 and is headquartered in Boston, MA.	2 years
Matthew L. Chase	M	-	University of Maine	4 years
Barry Peters	M	-	University of Maine	4 years
Matthew Wright	M	-	University of Maine	4 years
Andrew Sawyer	M	-	University of Maine	4 years
Kevin Blayne	M	-	University of Maine	4 years
Thomas Rowland	M	58	Alnara Pharmaceuticals, Inc. Alnara Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alnara Pharmaceuticals, Inc. develops and commercializes protein therapeutics for the treatment of metabolic diseases. It also develops liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT) for the treatment of exocrine pancreatic insufficiency (EPI). The company was founded by Christoph H. Westphal, Richard H. Aldrich and Alexy L. Margolin in 2008 and is headquartered in Boston, MA.	-
Kerry Perkins	M	-	University of Maine	4 years
Scott Toothaker	M	61	University of Maine	4 years
Clayton E. Andrews	M	61	University of Maine	4 years
Ashley L. Dombkowski	M	-	Alnara Pharmaceuticals, Inc. Alnara Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alnara Pharmaceuticals, Inc. develops and commercializes protein therapeutics for the treatment of metabolic diseases. It also develops liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT) for the treatment of exocrine pancreatic insufficiency (EPI). The company was founded by Christoph H. Westphal, Richard H. Aldrich and Alexy L. Margolin in 2008 and is headquartered in Boston, MA.	-
Charles G. Bridge	M	57	University of Maine	4 years
Brian Alan Bickford	M	-	University of Maine	3 years
Scott P. Conners	M	56	University of Maine	4 years
Glen Riley	M	61	University of Maine	4 years
Jenifer Lynne Butler	F	-	University of Maine	4 years
Lee R. Brettman	M	77	Alnara Pharmaceuticals, Inc. Alnara Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alnara Pharmaceuticals, Inc. develops and commercializes protein therapeutics for the treatment of metabolic diseases. It also develops liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT) for the treatment of exocrine pancreatic insufficiency (EPI). The company was founded by Christoph H. Westphal, Richard H. Aldrich and Alexy L. Margolin in 2008 and is headquartered in Boston, MA.	-
Paul Walsh	M	59	University of Maine	4 years
James A. Montembeau	M	-	University of Maine	4 years
Robert Gallotto	M	59	Alnara Pharmaceuticals, Inc. Alnara Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alnara Pharmaceuticals, Inc. develops and commercializes protein therapeutics for the treatment of metabolic diseases. It also develops liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT) for the treatment of exocrine pancreatic insufficiency (EPI). The company was founded by Christoph H. Westphal, Richard H. Aldrich and Alexy L. Margolin in 2008 and is headquartered in Boston, MA.	-
Darryl Withrow	M	59	University of Maine	4 years
Todd M. Pierce	M	-	University of Maine	4 years
Bruce G. Nickerson	M	-	University of Maine	3 years
Mark R. Stone	M	61	University of Maine	4 years
Richard L. Mooers	M	60	University of Maine	4 years
Robert Stolz	M	-	University of Maine	4 years
Ralph S. Baker	M	-	University of Maine	1 years
Matthew McHatten	M	-	University of Maine	4 years

Statistics

Country	Connections	% of total
United States	47	100.00%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections